Literature DB >> 15077176

Human papillomavirus type 77 E6 protein selectively inhibits p53-dependent transcription of proapoptotic genes following UV-B irradiation.

Silvia Giampieri1, Ramon García-Escudero, Judith Green, Alan Storey.   

Abstract

DNA damage, such as that elicited by UV-B, can induce either a cell cycle arrest or apoptosis that can be signalled by the p53 protein through the activation of a number of downstream cellular target genes. In contrast to oncogenic anogenital human papillomaviruses (HPVs), which mediate proteolytic degradation of p53, the E6 protein of cutaneous HPVs, such as HPV 77, do not promote p53 degradation. We have previously shown, however, that expression of HPV 77 E6 can effectively block UV-induced apoptosis in cells that have UV-activated p53. Here, we report that expression of the E6 protein from the cutaneous HPV 77 attenuates the UV-induced transactivation of p53-regulated proapoptotic genes Fas, PUMAbeta, Apaf-1, PIG3. This inhibition of p53-activation of proapoptotic genes by HPV77 E6 is exerted selectively, as the increased expression of p53 target genes involved in cell cycle arrest or regulatory functions regulation, such as p21 and Hdm2, is unaffected. Our data suggest that HPV 77 E6 may play an important role in specifically deregulating p53-dependent transactivation of proapoptotic genes upon UV-B irradiation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15077176     DOI: 10.1038/sj.onc.1207711

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  12 in total

Review 1.  Papillomavirus E6 oncoproteins.

Authors:  Scott B Vande Pol; Aloysius J Klingelhutz
Journal:  Virology       Date:  2013-05-24       Impact factor: 3.616

Review 2.  Oncogenic viruses and tumor glucose metabolism: like kids in a candy store.

Authors:  Evan Noch; Kamel Khalili
Journal:  Mol Cancer Ther       Date:  2012-01       Impact factor: 6.261

3.  E6 proteins from low-risk human papillomavirus types 6 and 11 are able to protect keratinocytes from apoptosis via Bak degradation.

Authors:  Michael P Underbrink; Crystal Dupuis; Jia Wang; Stephen K Tyring
Journal:  J Gen Virol       Date:  2016-01-07       Impact factor: 3.891

Review 4.  Papillomavirus E6 proteins.

Authors:  Heather L Howie; Rachel A Katzenellenbogen; Denise A Galloway
Journal:  Virology       Date:  2008-12-10       Impact factor: 3.616

5.  Identification of the regions of the HPV 5 E6 protein involved in Bak degradation and inhibition of apoptosis.

Authors:  Mark Simmonds; Alan Storey
Journal:  Int J Cancer       Date:  2008-11-15       Impact factor: 7.396

Review 6.  Recurrent respiratory papillomatosis.

Authors:  Naren N Venkatesan; Harold S Pine; Michael P Underbrink
Journal:  Otolaryngol Clin North Am       Date:  2012-06       Impact factor: 3.346

7.  Interferon-β induces cellular senescence in cutaneous human papilloma virus-transformed human keratinocytes by affecting p53 transactivating activity.

Authors:  Maria V Chiantore; Serena Vannucchi; Rosita Accardi; Massimo Tommasino; Zulema A Percario; Gabriele Vaccari; Elisabetta Affabris; Gianna Fiorucci; Giovanna Romeo
Journal:  PLoS One       Date:  2012-05-16       Impact factor: 3.240

8.  HPV8 early genes modulate differentiation and cell cycle of primary human adult keratinocytes.

Authors:  Baki Akgül; Lucy Ghali; Derek Davies; Herbert Pfister; Irene M Leigh; Alan Storey
Journal:  Exp Dermatol       Date:  2007-07       Impact factor: 3.960

9.  Thiothymidine plus low-dose UVA kills hyperproliferative human skin cells independently of their human papilloma virus status.

Authors:  Olivier Reelfs; Yao-Zhong Xu; Andrew Massey; Peter Karran; Alan Storey
Journal:  Mol Cancer Ther       Date:  2007-09       Impact factor: 6.261

10.  Human papillomavirus gene expression in cutaneous squamous cell carcinomas from immunosuppressed and immunocompetent individuals.

Authors:  Karin J Purdie; Thirunavukarasu Surentheran; Jane C Sterling; Louise Bell; Jane M McGregor; Charlotte M Proby; Catherine A Harwood; Judith Breuer
Journal:  J Invest Dermatol       Date:  2005-07       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.